On August 31, Cenovus rose 3.61% in pre-market trading, trading at $32.72/share, with turnover of $19,800, extending recent momentum following a wave of analyst upgrades and a robust second-quarter earnings report.
On the news front, multiple investment banks recently raised their price targets on Cenovus. UBS lifted its target from CA$46 to CA$52 while maintaining a Buy rating, RBC raised its target from C$47 to C$51 with an Outperform rating, and CIBC Capital Markets also increased its target. The consensus analyst target price has risen to CA$49.73, reinforcing bullish sentiment.
The upgrades followed Cenovus's Q2 results, in which the company reported EPS of $1.53, beating the consensus estimate of $1.37 by 11.68%, representing a 240% year-over-year increase. Revenue came in at CA$17.4 billion, surpassing the FactSet estimate of CA$16.87 billion. The combination of earnings outperformance and broad analyst endorsement continues to support the stock's upward trajectory.
Within the Integrated Oil & Gas sector, peers also traded higher, with Chevron up 1.85%, Suncor up 1.53%, Exxon Mobil up 1.28%, BP up 0.95%, and Shell up 0.86%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)